⌘K
Loading ticker…
Elutia Inc. Class A Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Elutia Inc. Class A Common Stock (ELUT) has a 3-month relative strength percentile of 30 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 50. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 8.0%, relative volume 0.94×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
30 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
ELUT is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $825K notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $825K |
| VXFVanguard Extended Market ETF | 0.00% | $250K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ELUT Jan avg: 34.94% median: 51.58% win: 67% σ: 43.00% n: 3 2023-09-08 → 2026-05-29 | ELUT Feb avg: 4.07% median: 1.86% win: 100% σ: 4.75% n: 3 2023-09-08 → 2026-05-29 | ELUT Mar avg: -15.01% median: -13.46% win: 0% σ: 7.21% n: 3 2023-09-08 → 2026-05-29 | ELUT Apr avg: -7.87% median: -8.70% win: 0% σ: 4.66% n: 3 2023-09-08 → 2026-05-29 | ELUT May avg: 2.99% median: 13.73% win: 67% σ: 21.79% n: 3 2023-09-08 → 2026-05-29 | ELUT Jun avg: 31.31% median: 31.31% win: 100% σ: 30.13% n: 2 2023-09-08 → 2026-05-29 (current) | ELUT Jul avg: -11.94% median: -11.94% win: 50% σ: 20.46% n: 2 2023-09-08 → 2026-05-29 | ELUT Aug avg: 12.32% median: 12.32% win: 100% σ: 0.01% n: 2 2023-09-08 → 2026-05-29 | ELUT Sep avg: -22.52% median: -7.07% win: 33% σ: 33.50% n: 3 2023-09-08 → 2026-05-29 | ELUT Oct avg: -10.68% median: -16.01% win: 33% σ: 11.17% n: 3 2023-09-08 → 2026-05-29 | ELUT Nov avg: 17.69% median: 29.38% win: 67% σ: 45.69% n: 3 2023-09-08 → 2026-05-29 | ELUT Dec avg: 7.19% median: 13.19% win: 67% σ: 14.79% n: 3 2023-09-08 → 2026-05-29 |